Annual report [Section 13 and 15(d), not S-K Item 405]

Cash, Cash Equivalents, and Marketable Securities

v3.26.1
Cash, Cash Equivalents, and Marketable Securities
 12 Months Ended
Dec. 31, 2025
Cash, Cash Equivalents, and Marketable Securities [Abstract]  
Cash, Cash Equivalents, and Marketable Securities

3. Cash, Cash Equivalents, and Marketable Securities

 

The following table summarizes the Company’s investments as of December 31, 2025 (in thousands):

 

    Amortized
Cost Basis		     Unrealized
Gains		     Unrealized
Losses		     Estimated
Fair Value		  
                         
Cash   $ 24,172     $
     -
     $
     -
     $ 24,172  
U.S. Treasury Bills     3,449      
-
      
-
       3,449  
Money Market     1,577                       1,577  
Investments in corporate bonds     12,072      
-
       (1 )     12,071  
Total cash, cash equivalents and investments in marketable securities   $ 41,270     $
-
     $ (1 )   $ 41,269  

The Company classifies its investments in corporate bonds as available-for-sale. Unrealized gains and losses on these securities are included as a component of comprehensive income (loss). The Company did not hold any investments in corporate bonds as of December 31, 2024.

 

On December 31, 2025, the remaining contractual maturities of all the Company’s available-for-sale investments were less than twelve months. As of December 31, 2025, the Company has not established an allowance for credit losses for any of its available-for-sale securities.